Showing results (171-180 of 203) with videos related to
Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|March 7, 2012
Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitorMeiqing Lu, Peter J Felock, Vandna Munshi, et al.Gastroenterology|June 15, 2016
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and SofosbuvirChristoph Sarrazin, Hadas Dvory-Sobol, Evguenia S Svarovskaia, et al.Nature Structural & Molecular Biology|April 27, 2004
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovirSteve Tuske, Stefan G Sarafianos, Arthur D Clark, et al.Lancet (London, England)|August 4, 2009
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trialJeffrey L Lennox, Edwin DeJesus, Adriano Lazzarin, et al.Antimicrobial Agents and Chemotherapy|January 1, 2014
In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitorMing-Tain Lai, Meizhen Feng, Jean-Pierre Falgueyret, et al.Ebiomedicine|October 2, 2015
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected IndividualsFrancesco Andrea Procopio, Rémi Fromentin, Deanna A Kulpa, et al.Journal of Hepatology|January 22, 2017
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcomeStefan Zeuzem, Masashi Mizokami, Stephen Pianko, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analysesJeffrey L Lennox, Edwin Dejesus, Daniel S Berger, et al.Annals of the New York Academy of Sciences|March 26, 2011
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentariumBach-Yen T Nguyen, Robin D Isaacs, Hedy Teppler, et al.Journal of Computer-Aided Molecular Design|May 24, 2011
Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metricsWan F Lau, Jane M Withka, David Hepworth, et al.Pageof 21